(XDND) Xtrackers MSCI North - Ratings and Ratios
US Stocks, High Dividend, Equity, Income, Investments
Description: XDND Xtrackers MSCI North
The Xtrackers MSCI North America High Dividend Yield UCITS ETF1C (XETRA:XDND) is a US Equity Income ETF that tracks the Morningstar US High Div Yld NR USD Index, providing investors with exposure to high-dividend yielding stocks in the North American market. The fund is domiciled in Germany and offers a diversified portfolio of dividend-paying stocks.
Analyzing the ETFs characteristics, its clear that its designed to appeal to income-seeking investors. By tracking a high-dividend yield index, XDND provides a regular income stream, which can be attractive in a low-interest-rate environment. The ETFs underlying index is likely to be comprised of established companies with a history of paying consistent dividends, potentially offering a relatively stable source of returns.
From a technical analysis perspective, the current price of 49.52 is above the 20-day Simple Moving Average (SMA) of 48.34, indicating a short-term bullish trend. However, the price is below the 50-day SMA of 50.25 and the 200-day SMA of 52.17, suggesting a longer-term bearish trend. The Average True Range (ATR) of 1.03, or 2.08%, indicates moderate volatility. Given these technical indicators, a potential trading strategy could be to wait for a breakout above the 50-day SMA, which could signal a reversal of the longer-term downtrend.
Fundamentally, the ETFs Assets Under Management (AUM) of 143.55M EUR suggest a relatively small but still viable fund. To forecast the ETFs future performance, we can combine technical and fundamental data. Assuming the underlying index continues to track the performance of high-dividend yielding stocks in the North American market, and considering the current technical trends, a potential price target for XDND could be around 53-55, representing a 7-11% increase from the current price. However, this forecast is contingent upon the ETFs ability to break through its current resistance levels, such as the 50-day SMA.
In conclusion, XDND offers a diversified exposure to high-dividend yielding stocks in North America, which can be an attractive feature for income-focused investors. While the current technical trends are mixed, a breakout above the 50-day SMA could signal a potential buying opportunity, with a target price of 53-55. Investors should closely monitor the ETFs price action and adjust their strategies accordingly.
Additional Sources for XDND ETF
XDND ETF Overview
Market Cap in USD | 166m |
Category | US Equity Income |
TER | 0.39% |
IPO / Inception | 2014-01-29 |
XDND ETF Ratings
Growth Rating | 47.9 |
Fundamental | - |
Dividend Rating | 0.11 |
Rel. Strength | -16.7 |
Analysts | - |
Fair Price Momentum | 46.45 EUR |
Fair Price DCF | - |
XDND Dividends
Currently no dividends paidXDND Growth Ratios
Growth Correlation 3m | 18.2% |
Growth Correlation 12m | -40% |
Growth Correlation 5y | 89.9% |
CAGR 5y | 9.80% |
CAGR/Max DD 5y | 0.54 |
Sharpe Ratio 12m | -0.59 |
Alpha | -10.68 |
Beta | 0.467 |
Volatility | 89.36% |
Current Volume | 7k |
Average Volume 20d | 1.9k |
Stop Loss | 48.1 (-3.2%) |
As of August 05, 2025, the stock is trading at EUR 49.68 with a total of 6,988 shares traded.
Over the past week, the price has changed by -1.29%, over one month by -0.16%, over three months by +1.96% and over the past year by +2.84%.
Partly, yes. Based on ValueRay´s Analyses, Xtrackers MSCI North (XETRA:XDND) is currently (August 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 47.88 and therefor an somewhat technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of XDND is around 46.45 EUR . This means that XDND is currently overvalued and has a potential downside of -6.5%.
Xtrackers MSCI North has no consensus analysts rating.
According to our own proprietary Forecast Model, XDND Xtrackers MSCI North will be worth about 53.1 in August 2026. The stock is currently trading at 49.68. This means that the stock has a potential upside of +6.9%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 53.1 | 6.9% |